Metraipolis › archive › dc_0edadf625aee

Matrix Metalloproteinase-9 (MMP-9) as a Therapeutic Target: Insights into Molecular Pathways and Clinical Applications — Europe PMC PMID:41304763

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41304763
DOI
10.3390/pharmaceutics17111425
License (as archived)
solo-consultazione
Archived
2026-11-08T19:13:13.038Z
SHA-256 of the archived text
f1dcf38f48abc8511eafc7d0836491d5e838b29b2f5695aa50fe8b7e32187a97
Stable URL of this page
https://metraipolis.com/documento/dc_0edadf625aee

How to cite

Matrix Metalloproteinase-9 (MMP-9) as a Therapeutic Target: Insights into Molecular Pathways and Clinical Applications — Europe PMC PMID:41304763 — Europe PMC (en), https://europepmc.org/article/MED/41304763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0edadf625aee (Metraipolis archive dc_0edadf625aee, sha256 f1dcf38f48abc8511eafc7d0836491d5e838b29b2f5695aa50fe8b7e32187a97)
BibTeX
@misc{dc0edadf625aee,
  title = {Matrix Metalloproteinase-9 (MMP-9) as a Therapeutic Target: Insights into Molecular Pathways and Clinical Applications — Europe PMC PMID:41304763},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41304763},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0edadf625aee; sha256 f1dcf38f48abc8511eafc7d0836491d5e838b29b2f5695aa50fe8b7e32187a97},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41304763. Agents can read the archived copy with the MCP tool read_document.